http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020166820-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80cbc9fc3a4bde51deab18978496c91b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
| filingDate | 2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_367b7ecf53d47c43692df4c225f79968 |
| publicationDate | 2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020166820-A1 |
| titleOfInvention | Composition for subcutaneous injection containing microparticles comprising finasteride |
| abstract | The present invention provides a composition for subcutaneous injection containing microparticles comprising finasteride, the composition comprising: microparticles comprising finasteride and biodegradable polymer; and a suspension solvent. The composition for subcutaneous injection of the present invention is provided in a subcutaneously injectable form, not in an oral administration form, and thus there is no need for a user to store the composition, and a hair loss treatment effect by finasteride can be exhibited through a method of direct administration at a hospital, and thus ease of storage and handling is excellent. When microparticles comprising finasteride are administered using the composition for subcutaneous injection of the present invention, a long-term drug administration effect over a period of 1-3 months can be maintained. In addition, in the present invention, as the diameter of particles is formed to a uniform micro-size, the release of a drug from microparticles is controlled, thereby enabling an effective drug concentration to be constantly maintained, and the present invention can be provided as a composition for injection, in which, when applied to an injection consisting of a uniform size of particles and administered as an injection to a patient, the sense of foreign matter and pain are reduced. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114002357-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484495-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3842036-A1 |
| priorityDate | 2019-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.